These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 17986063)
1. Bexarotene and narrowband ultraviolet B phototherapy combination treatment for mycosis fungoides. Lokitz ML; Wong HK Photodermatol Photoimmunol Photomed; 2007 Dec; 23(6):255-7. PubMed ID: 17986063 [TBL] [Abstract][Full Text] [Related]
2. Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB-NB. D'Acunto C; Gurioli C; Neri I J Dermatolog Treat; 2010 Jan; 21(1):45-8. PubMed ID: 19603308 [TBL] [Abstract][Full Text] [Related]
3. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes. Gökdemir G; Barutcuoglu B; Sakiz D; Köşlü A J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):804-9. PubMed ID: 16898902 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of narrowband UVB vs. PUVA in patients with early-stage mycosis fungoides. Ponte P; Serrão V; Apetato M J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):716-21. PubMed ID: 19929938 [TBL] [Abstract][Full Text] [Related]
5. Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-gamma and narrowband UVB in patients with mycosis fungoides. Shimauchi T; Sugita K; Nishio D; Isoda H; Abe S; Yamada Y; Hino R; Ogata M; Kabashima K; Tokura Y J Dermatol Sci; 2008 Jun; 50(3):217-25. PubMed ID: 18243665 [TBL] [Abstract][Full Text] [Related]
6. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study. Ahmad K; Rogers S; McNicholas PD; Collins P Acta Derm Venereol; 2007; 87(5):413-7. PubMed ID: 17721648 [TBL] [Abstract][Full Text] [Related]
7. Narrow-band ultraviolet B phototherapy for early stage mycosis fungoides. Xiao T; Xia LX; Yang ZH; He CD; Gao XH; Chen HD Eur J Dermatol; 2008; 18(6):660-2. PubMed ID: 18955199 [TBL] [Abstract][Full Text] [Related]
8. Juvenile mycosis fungoides treated with bexarotene and PUVA. Rodríguez-Vázquez M; García-Arpa M; González-García J Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731 [TBL] [Abstract][Full Text] [Related]
9. Phototherapy for mycosis fungoides. Dogra S; Mahajan R Indian J Dermatol Venereol Leprol; 2015; 81(2):124-35. PubMed ID: 25751327 [TBL] [Abstract][Full Text] [Related]
10. Mycosis fungoides with depigmentation secondary to treatment. Firoz B; Kovich OI; Latkowski JA Dermatol Online J; 2007 Jan; 13(1):18. PubMed ID: 17511951 [TBL] [Abstract][Full Text] [Related]
11. Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoides. Boztepe G; Sahin S; Ayhan M; Erkin G; Kilemen F J Am Acad Dermatol; 2005 Aug; 53(2):242-6. PubMed ID: 16021117 [TBL] [Abstract][Full Text] [Related]
12. Narrow-band ultraviolet therapy in early-stage mycosis fungoides: study on 20 patients. Brazzelli V; Antoninetti M; Palazzini S; Prestinari F; Borroni G Photodermatol Photoimmunol Photomed; 2007 Dec; 23(6):229-33. PubMed ID: 17986058 [TBL] [Abstract][Full Text] [Related]
13. PUVA therapy and narrowband UVB therapy in Tunisian patients with mycosis fungoides. Khaled A; Fazaa B; Goucha S; Zeglaoui F; Kamoun MR Therapie; 2009; 64(6):389-94. PubMed ID: 20025842 [TBL] [Abstract][Full Text] [Related]
14. A large scale analytical study on efficacy of different photo(chemo)therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides. El-Mofty M; Mostafa WZ; Bosseila M; Youssef R; Esmat S; El Ramly A; Fawzi M; Mahgoub D; Nagui N; Mashaly HM; El-Fangary M; Fathy M Dermatol Ther; 2010; 23(4):428-34. PubMed ID: 20666832 [TBL] [Abstract][Full Text] [Related]
15. Treatment of mycosis fungoides with oral bexarotene combined with PUVA. Stern DK; Lebwohl M J Drugs Dermatol; 2002 Sep; 1(2):134-6. PubMed ID: 12847736 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056). Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950 [TBL] [Abstract][Full Text] [Related]
17. Narrow band UVB (311 nm), psoralen UVB (311 nm) and PUVA therapy in the treatment of early-stage mycosis fungoides: a right-left comparative study. El-Mofty M; El-Darouty M; Salonas M; Bosseila M; Sobeih S; Leheta T; Nada H; Tawdy A; Amin I; El-Enany G Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):281-6. PubMed ID: 16313238 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of narrowband ultraviolet B monotherapy versus combination therapy with systemic agents in patients with early-stage mycosis fungoides and the association with plaque lesions. Qin Y; Lin Y; Chen Z; Zhang Q; Li Y; Wen Y; Tu P; Gao P; Wang Y J Evid Based Med; 2024 Jun; 17(2):390-398. PubMed ID: 38898743 [TBL] [Abstract][Full Text] [Related]
19. Role of radiation therapy in mycosis fungoides refractory to systemic therapy. de Sanctis V; Persechino S; Fanelli A; Valeriani M; Bracci S; D'Arienzo M; Monarca B; Caperchi C; Raffa S; Enrici RM Eur J Dermatol; 2011; 21(2):213-7. PubMed ID: 21489904 [TBL] [Abstract][Full Text] [Related]
20. The efficacy of combination treatment with narrowband UVB (TL-01) and acitretin vs narrowband UVB alone in plaque-type psoriasis: a retrospective study. Kampitak T; Asawanonda P J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S20-4. PubMed ID: 17718265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]